Transaction in Own Shares

AI SummaryClose X

RTW Biotech Opportunities bought back 497,014 ordinary shares on 16 November 2026 at $2.47 per share, with the repurchased shares to be held in treasury. After settlement, issued share capital is 345,967,440, of which 28,670,806 ordinary shares are held in treasury (no voting rights), leaving total voting rights of 317,296,634. Buybacks are being conducted under shareholder authority permitting repurchase of up to 14.99% of shares (authority runs until the next shareholder authority, expected at the 2027 AGM), the company will not pay a price that would equal a premium to net asset value, and purchases depend on market conditions.

Disclaimer*

UK 100

Latest directors dealings